FDA Inspection 1113157 — Strive Pharmaceuticals, Inc.
The FDA completed an inspection of Strive Pharmaceuticals, Inc. on December 6, 2019 in East Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 6, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- East Brunswick, NJ (United States)